abstract |
The present application relates to methods for the treatment of eczema and uses of a dairy-derived composition. The treatment involves oral administration of 800 mg/day of a composition comprising TGF-ß1, TGF-ß2, IGF-1 and 60% (w/w) beta-lactoglobulin derived from whey. |